KDR and neoplasm: ATP7A may suppress tumor cell growth and migration by inhibiting the activity of LOX.ATP7A may promote angiogenesis by combining with VEGFR2.ATP7A or ATP7B can bind to platinum drugs to expel it from cancer cells, producing chemotherapy drug resistance.